53 / 135
Annual Report 2015
二零一五年年報
51
Directors’ Report
董事會報告書
Share Option Schemes (continued)
Share Option Scheme 2014
(continued)
The subscription amount payable in respect of each share option upon
exercise of an option shall be determined by the Board and shall be not less
than the greater of:
(i) the closing price of the shares on the SEHK’s daily quotation sheet on the
date, which must be a business day, of a written offer of such option (the
“Date of Grant”); and
(ii) the average closing price of the shares on the SEHK as stated in the
SEHK’s daily quotation sheets for the five business days immediately
preceding the Date of Grant.
At Board meeting on 24 June 2014, the Board approved an allotment of
share options under the Share Option Scheme 2014 to certain individuals
(the “Grantees”) entitling them to subscribe for a total of 12,200,000 ordinary
shares of the Company at HK$1.90 per share. The terms are the same as
those stated above. The Grantees may exercise the share options subject
to the conditions in respective option offering letter. The details of vesting
conditions are set out in
Note 24(a)
under the heading “Notes to the Financial
Statements” on pages 111 to 112.
At the Annual General Meeting of the Company on 8 May 2015, shareholders
approved the amendments to clauses 10.1(D), 10.1(E) and 2.1 of the Share
Option Scheme 2014. Such amendments to the Share Option Scheme 2014
give the Board a discretion to waive or extend the 90-day Limitation with
authority to impose conditions to any such waiver or extension and to provide
an appropriate exercise period for each grant of options during the Scheme
Period. This provides the Board with necessary flexibility it needs to deal, in
the best interest of the Company, with the different types of situations that
may arise over the course of the ten-year validity period of the Share Option
Scheme 2014.
At its meeting on 30 June 2015, the Board approved an allotment of share
options under the amended Share Option Scheme 2014 to Grantees entitling
them to subscribe for a total of 7,600,000 ordinary shares of the Company at
HK$1.78 per share. The terms are the same as the amended Share Option
Scheme 2014. The Grantees may exercise the share options subject to the
conditions in respective option offering letter. The vesting conditions are also
set out in
Note 24(a)
under the heading “Notes to the Financial Statements”
on pages 111 to 112.
購股權計劃（續）
二零一四年購股權計劃（續）
因行使購股權而須就每份購股權支付的認購款項，將由董事
會釐定，且不得低於下列各項中的較高者：
(i)
於購股權的書面要約日期（「授出日期」，必須為營業
日），於香港聯交所每日報價表所列股份的收市價；及
(ii)
緊接授出日期前五個營業日，於香港聯交所每日報價
表所列股份在香港聯交所的平均收市價。
董事會於二零一四年六月二十四日舉行的會議上，批准根據
二零一四年購股權計劃向若干個人（「承授人」）配發購股權，
讓彼等可以每股港幣
1.90
元認購合共
12,200,000
股本公司普
通股，有關條款與上文所述者相同。承授人可根據購股權要
約函件所列的條件行使購股權。歸屬條件詳情載於第
111
至
112
頁「財務報表附註」內
附註
24(a)
。
股東於二零一五年五月八日舉行的本公司股東週年大會上，
批准修訂二零一四年購股權計劃之第
10.1(D)
、
10.1(E)
及
2.1
條條款。修訂二零一四年購股權計劃授權董事會酌情豁免或
延長
90
日限制，並規定豁免或延期的相應條件以及計劃期
間內所授各項購股權適用的行使期。此舉可讓董事會以符合
本公司最佳利益的方式靈活處理二零一四年購股權計劃十年
有效期間可能發生的各類情況。
於二零一五年六月三十日舉行的會議上，董事會批准根據二
零一四年購股權計劃向承授人配發購股權，讓彼等可以每股
港幣
1.78
元認購合共
7,600,000
股本公司普通股，有關條款
與上文所述者相同。承授人可根據購股權要約函件所列的條
件行使購股權。歸屬條件詳情載於第
111
至
112
頁「財務報表
附註」內
附註
24(a)
。